SEC 13F Intelligence

Davis Selected Advisers / DGX

Davis Selected Advisers’s Quest Diagnostics Inc Position

Does Davis Selected Advisers own Quest Diagnostics Inc (DGX)? Yes — 1.62M shares worth $317M (+1.46% of its 13F portfolio) as of Q1 2026, up from 1.59M shares the prior filed quarter.

Position Value
$317M
Q1 2026
Shares
1.62M
% of Portfolio
+1.46%
Quarters Held
30
currently held

Position History DGX

Reported value by quarter
Q4 ’18: $66MQ4 ’18Q1 ’19: $327MQ2 ’19: $407MQ3 ’19: $426MQ4 ’19: $417MQ4 ’19Q1 ’20: $311MQ2 ’20: $442MQ3 ’20: $429MQ4 ’20: $349MQ4 ’20Q1 ’21: $357MQ2 ’21: $372MQ3 ’21: $399MQ4 ’21: $347MQ4 ’21Q1 ’22: $266MQ2 ’22: $251MQ3 ’22: $230MQ4 ’22: $287MQ4 ’22Q1 ’23: $215MQ2 ’23: $213MQ3 ’23: $203MQ4 ’23: $368MQ4 ’23Q1 ’24: $317MQ2 ’24: $327MQ3 ’24: $372MQ4 ’24: $362MQ4 ’24Q1 ’25: $404MQ2 ’25: $243MQ3 ’25: $259MQ4 ’25: $276MQ4 ’25Q1 ’26: $317Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.62M$317M+1.46%
Q4 20251.59M$276M+1.24%
Q3 20251.36M$259M+1.35%
Q2 20251.35M$243M+1.30%
Q1 20252.39M$404M+2.33%
Q4 20242.40M$362M+2.10%
Q3 20242.40M$372M+2.09%
Q2 20242.39M$327M+1.90%
Q1 20242.38M$317M+1.78%
Q4 20232.67M$368M+2.08%
Q3 20231.67M$203M+1.27%
Q2 20231.51M$213M+1.30%
Q1 20231.52M$215M+1.42%
Q4 20221.84M$287M+1.95%
Q3 20221.87M$230M+1.63%
Q2 20221.89M$251M+1.61%
Q1 20221.95M$266M+1.35%
Q4 20212.01M$347M+1.61%
Q3 20212.74M$399M+1.84%
Q2 20212.82M$372M+1.53%
Q1 20212.78M$357M+1.56%
Q4 20202.93M$349M+1.68%
Q3 20203.75M$429M+2.39%
Q2 20203.87M$442M+2.55%
Q1 20203.87M$311M+2.10%
Q4 20193.90M$417M+1.99%
Q3 20193.98M$426M+2.14%
Q2 20194.00M$407M+2.01%
Q1 20193.64M$327M+1.61%
Q4 2018798.4K$66M+0.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Davis Selected Advisers’s full portfolio or all institutional holders of DGX.